STEPHANIE CONSIGLIO: Open Payments
NPI 1518575687 · CHICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,949 in 96 payments from 16 companies in 2025. Trend: 2023 $2,314 · 2024 $3,073 · 2025 $1,949
Food & beverage: $1,775Education: $174
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $394 |
| GENZYME CORPORATION | 16 | $370 |
| ABBVIE INC. | 18 | $295 |
| Lilly USA, LLC | 10 | $196 |
| Incyte Corporation | 5 | $112 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 5 | $99 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| LEO Pharma Inc. | 4 | $70 |
| Organon LLC | 2 | $56 |
Products named: DUPIXENT, TREMFYA, TALTZ, RINVOQ, SKYRIZI, OPZELURA, COSENTYX, JUBLIA.
Industry payments across CA — which companies pay providers there.
